2016
DOI: 10.1158/0008-5472.can-15-1322
|View full text |Cite
|
Sign up to set email alerts
|

miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer

Abstract: miR-214 and miR-148b have been proposed to antagonize the effects of each other in enabling or blocking metastasis, respectively. In this study, we provide evidence deepening their role and interrelationship in the process of metastatic dissemination. Depleting miR-214 or elevating miR-148b blocked the dissemination of melanoma or breast cancer cells, an effect that could be accentuated by dual alteration. Mechanistic investigations indicated that dual alteration suppressed passage of malignant cells through t… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
74
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(75 citation statements)
references
References 48 publications
1
74
0
Order By: Relevance
“…Interestingly, HIF-1α, but not HIF-2α, was also required for the hypoxia-induced expression of ITGB1 (the obligate partner of ITGA1). The findings suggest that integrin inhibitors, which are being tested in clinical trials (28,60), may hold promise for patients with hypoxic tumors and patients with increased levels of ITGA5 due to oncogene activation by ERBB2 (61), c-Myc (62), or by miRNA regulation (63). ATN-161 (Ac-PHSCN-NH2), a peptide that binds to α5β1 and αvβ3, was shown to block breast cancer growth and bone colonization after intracardiac injection of MDA-MB-231 cells (64).…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, HIF-1α, but not HIF-2α, was also required for the hypoxia-induced expression of ITGB1 (the obligate partner of ITGA1). The findings suggest that integrin inhibitors, which are being tested in clinical trials (28,60), may hold promise for patients with hypoxic tumors and patients with increased levels of ITGA5 due to oncogene activation by ERBB2 (61), c-Myc (62), or by miRNA regulation (63). ATN-161 (Ac-PHSCN-NH2), a peptide that binds to α5β1 and αvβ3, was shown to block breast cancer growth and bone colonization after intracardiac injection of MDA-MB-231 cells (64).…”
Section: Discussionmentioning
confidence: 99%
“…It has been previously reported that miR-148b serves a role in regulating several types of tumors (27)(28)(29). Furthermore, it has been demonstrated that miR-148b expression is reduced in the plasma samples of patients with NSCLC (23).…”
Section: Discussionmentioning
confidence: 98%
“…Similarly, miR‐214 was reported to act as a tumor suppressor in cervical cancer by suppressing RelA, β‐catenin and STAT3 . However, in breast cancer and melanoma, miR‐214 was shown to inhibit tumor cell dissemination . In gastric cancer tissue (GCT) and GCT‐derived mesenchymal stem cells, from 10 patients, miR‐214 expression was higher compared with noncancerous gastric tissue .…”
Section: Discussionmentioning
confidence: 99%